Cancer Research The Future of Cancer Research: Science and Patient Impact
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 36, 3588-3593, October 1, 1976]
© 1976 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sippel, A. E.
Right arrow Articles by Feigelson, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sippel, A. E.
Right arrow Articles by Feigelson, P.

Comparison of in Vivo Translation Rates and Messenger RNA Levels of {alpha}2U-Globulin in Rat Liver and Morris Hepatoma 5123D1

Albrecht E. Sippel2, David T. Kurtz, Harold P. Morris3 and Philip Feigelson4

Institute of Cancer Research and Department of Biochemistry, Columbia University, New York, New York 10032

The synthesis of the male rat hepatic protein {alpha}2U-globulin has been examined in Morris hepatoma 5123D and male host liver using pulse incorporation of labeled amino acids in vivo, followed by immunoprecipitation of the newly synthesized {alpha}2U-globulin from the soluble protein fraction of liver and hepatoma tissue. It was found that no {alpha}2U-globulin synthesis occurs in hepatoma tissue, whereas host liver synthesizes {alpha}2U-globulin at a normal level (0.9 to 1.0% of total hepatic protein synthesis). A variety of liver-derived cell culture lines also did not have {alpha}2U-globulin synthesis.

The level of the specific mRNA coding for {alpha}2U-globulin can be quantitated using in vitro translation of polyadenylate-containing RNA in a Krebs II ascites cell-free translational system, followed by immunoprecipitation of the {alpha}2U-globulin synthesized in vitro. Using this technique, it was found that host liver contained {alpha}2U-globulin mRNA at normal levels, whereas hepatoma tissue contained no detectable mRNA coding for this protein. Thus, {alpha}2U-globulin synthesis is deleted in the minimal-deviation hepatoma 5123D as a consequence of the inability of that tissue to produce functional mRNA coding for {alpha}2U-globulin. The implications for the regulation of gene expression in malignant cells are discussed.

1 Supported by Grants CA-02332, CA-10729, and CRTY 05011 from the NIH.

2 Present address: Max-Planck-Institut fur Molekulare Genetik, 1 Berlin 33, Ihnestraße 63–73, West Germany.

3 Present address: Department of Biochemistry, Howard University, College of Medicine, Washington, D. C.

4 To whom requests for reprints should be addressed.

Received 3/ 3/76. Accepted 6/15/76.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1976 by the American Association for Cancer Research.